Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Revenue

Niagen Bioscience had revenue of $31.47M in the quarter ending March 31, 2026, with 3.26% growth. This brings the company's revenue in the last twelve months to $130.42M, up 20.84% year-over-year. In the year 2025, Niagen Bioscience had annual revenue of $129.42M with 29.95% growth.

• Revenue (ttm): $130.42M
• Revenue Growth: +20.84%
• P/S Ratio: 2.25
• Revenue / Employee: $1,114,667
• Employees: 117
• Market Cap: 287.32M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	129.42M	29.83M	29.95%
Dec 31, 2024	99.60M	16.03M	19.18%
Dec 31, 2023	83.57M	11.52M	15.99%
Dec 31, 2022	72.05M	4.60M	6.82%
Dec 31, 2021	67.45M	8.19M	13.82%
Dec 31, 2020	59.26M	12.97M	28.01%
Dec 31, 2019	46.29M	14.73M	46.69%
Dec 31, 2018	31.56M	10.36M	48.85%
Dec 31, 2017	21.20M	-463.60K	-2.14%
Dec 31, 2016	21.66M	3.78M	21.13%
Jan 2, 2016	17.88M	2.57M	16.79%
Jan 3, 2015	15.31M	5.15M	50.71%
Dec 28, 2013	10.16M	-1.45M	-12.48%
Dec 29, 2012	11.61M	3.50M	43.12%
Dec 31, 2011	8.11M	546.24K	7.22%
Jan 1, 2011	7.57M	1.79M	30.95%
Jan 2, 2010	5.78M	1.27M	28.22%
Jan 3, 2009	4.51M	-247.77K	-5.21%
Dec 29, 2007	4.75M	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error